News & Insights | Access & Channel

This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Study finds high adherence to oral CLL/SLL therapy with IHSSP pharmacist support

HCPs and patients agree: Insurance, PBM practices need to change

Integrated specialty pharmacies are making an impact

Navigating cell and gene therapeutic access

Rare disease therapeutic development facing challenges

Re-engineering your drug supply chain: Lessons from a specialty distribution transition

Report finds 15% of US households affected by rare disease

Specialty Therapies and Field Reimbursement Services: Driving Better Outcomes for Brands and Patients

Payers are harnessing AI to enhance data utilization

Red Nucleus acquires COEUS

Market access on the Hill: What’s possible in the next two years

A path for healthier patients: Integrated specialty pharmacy model

NCPA calls for immediate freeze of Medicare Drug Price Negotiation to protect pharmacies and patients

Navigating product launches under budget constraints

Raising the Bar in Patient Experience

Early market access decisions are key for biotech commercialization success

FTC calls out significant markups by PBMs in the specialty generic drug market

Attention to PBM vertical integration will continue through 2025

Data show drug shortages are bigger than ever

2025: Continued chaos at the retail pharmacy level

Quick Links